JN BIOTECH ApS: Financial statements 2021
CVR: 25325001
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
JN BIOTECH ApS (CVR 25325001) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 115,553 and a net result of DKK 1,643,481. Equity in the 2021 report amounted to DKK 15,666,876. The solvency ratio was 95%.
- Gross Profit
- DKK 115,553
- Profit/Loss
- DKK 1,643,481
- Equity
- DKK 15,666,876
- Total Assets
- DKK 16,489,730
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 116K | 1.6M | 15.7M | 0 |
| 2018 | - | 73K | 12.8M | 13.7M | 0 |
| 2017 | - | 81K | 103K | 872K | 0 |
| 2016 | - | 112K | 100K | 768K | - |
| 2015 | - | 199K | 136K | 668K | - |
Official annual report
Find more companies like JN BIOTECH ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout JN BIOTECH ApS
JN BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Andre personlige serviceydelser i.a.n.. The management consists of Jens Bredal Nielsen. The company is owned by JBN Biotech ApS. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK 90,325 and a net result of DKK 104,408 compared with DKK 60,995 the year before. Equity in the 2025 report amounted to DKK 821,161.